Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Anti-Helicobacter Pylori IgM Kit ELISA

Le kit ELISA Anti-Helicobacter Pylori IgM (ABIN997008) Humain est un kit ELISA Colorimetric conçu pour quantifier Humain Anti-Helicobacter Pylori IgM.
N° du produit ABIN997008
496,57 €
Plus frais de livraison 40,00 € et TVA
96 tests
Destination: France
Envoi sous 8 à 12 jours ouvrables

Aperçu rapide pour Anti-Helicobacter Pylori IgM Kit ELISA (ABIN997008)

Antigène

Anti-Helicobacter Pylori IgM

Reactivité

  • 4
  • 1
Humain

Méthode de détection

Colorimetric

Type de méthode

Competition ELISA

Application

ELISA

Type d'échantillon

Serum
  • Fonction

    The ELISA, Helicobacter pylori IgM is intended for use in evaluating the serologic status to H. pylori infection in patients with gastrointestinal symptoms.

    Analytical Method

    Qualitative

    Specificité

    98%

    Sensibilité

    98%
  • Volume d'échantillon

    5 μL

    Durée du test

    1 - 2 h

    Plaque

    Pre-coated

    Restrictions

    For Research Use only
  • Stock

    4 °C

    Date de péremption

    12-18 months
  • Antigène

    Anti-Helicobacter Pylori IgM

    Classe de substances

    Antibody

    Sujet

    Helicobacter pylori is a spiral bacterium cultured from human gastric mucosa by Marshall in 1982. Studies have indicated that the presence of H. pylori is associated with a variety of gastrointestinal diseases including gastritis, duodenal and gastric ulcer, non-ulcer dyspepsia, gastric adenocarcinoma and lymphoma. The organism is present in 95-98% of patients with duodenal ulcer and 60-90% of patients with gastric ulcers. The studies have also demonstrated that removal of the organism by antimicrobial therapy is correlated with the resolution of symptoms and cure of diseases. Patients who present with clinical symptoms relating to the gastrointestinal tract can be diagnosed for H. pylori infection by two methods: 1) invasive techniques include biopsy followed by culture or histologic examination of biopsy specimen or direct detection of urease activity. 2) non-invasive techniques include urea breath tests and serological methods. All of the testing performed on biopsy samples are subject to errors related to sampling and interference of contaminated bacteria.
Vous êtes ici:
Chat with us!